Back to video list Back to Home The Evolution of Pharmacological Treatments and Treatment Goals in MDD and Anxiety You may also like Depression Interview Cognitive symptoms in depression Schizophrenia Congress highlights Article Hippocampal N-methyl-D-aspartate receptor hypofunction in first-episode psychosis pathophysiology Migraine Alzheimer's Disease Article The Relationship between Alzheimer’s Disease and Migraine Schizophrenia Article Strategies for reducing the duration of untreated psychosis